OncoMatch/Clinical Trials/NCT05672108
Phase II Trial of Lung Chemoemobolization
Is NCT05672108 recruiting? Yes, currently enrolling (May 2026). This Phase 2 trial studies multiple treatments including Ethiodized Oil and Mitomycin for lung non-small cell carcinoma.
Treatment: Ethiodized Oil · Mitomycin · Tris-acryl Gelatin Microspheres — This phase II trial evaluates how well transarterial chemoembolization (TACE) works for treating patients with non-small cell lung cancer or lung metastases. TACE is a minimally invasive procedure that involves injecting chemotherapy directly into an artery that supplies blood to tumors, and then blocking off the blood supply to the tumors. Mitomycin (chemotherapy), Lipiodol (drug carrier), and Embospheres (small plastic beads that block off the artery) are injected into the tumor-feeding artery. This traps the chemotherapy inside the tumor and also cuts off the tumor\'s blood supply. As a result, the tumor is exposed to a high dose of chemotherapy, and is also deprived of nutrients and oxygen. TACE can be effective at controlling or stopping the growth of lung tumors.
Check if I qualifyExtracted eligibility criteria
Cancer type
Non-Small Cell Lung Carcinoma
Colorectal Cancer
Sarcoma
Performance status
ECOG 0–2(Ambulatory, capable of self-care)
Lab requirements
Blood counts
Platelets < 50,000 (after transfusion, if needed); INR > 2 (after transfusion, if needed); Hemoglobin < 7 (after transfusion, if needed) [all excluded]
Kidney function
estimated glomerular filtration rate (eGFR) < 30 mL/min/1.73 m^2 [excluded]
Platelets < 50,000 (after transfusion, if needed); INR > 2 (after transfusion, if needed); Hemoglobin < 7 (after transfusion, if needed); Renal failure (eGFR < 30 mL/min/1.73 m^2)
Structured fields extracted by AI. May contain errors — verify against the official protocol.
US trial sites
- City of Hope Medical Center · Duarte, California
- Memorial Sloan Kettering Cancer Center · New York, New York
Showing up to 5 US sites. See all sites on ClinicalTrials.gov →
Could you qualify for this trial?
Enter your biomarker results to see how this trial's eligibility criteria match your specific cancer profile.
Check if I qualify